Matrix metalloproteinase-9 is associated with relapse and prognosis of patients with colorectal cancer

Annals of Surgical Oncology

Volumn 19, Issue 1, 2012, Pages 318-325

  Chu, Dake ^a   Zhao, Zhengwei ^a   Zhou, Yi ^b   Li, Yunming ^c   Li, Jipeng ^a   Zheng, Jianyong ^a   Zhao, Qingchuan ^a   Wang, Weizhong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Tianjin Union Medicine Centre   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B;

ADULT; AGE; ARTICLE; CANCER INVASION; CANCER PROGNOSIS; CANCER RELAPSE; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; GENDER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; TUMOR LOCALIZATION;

CASE-CONTROL STUDIES; COLON; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RECTUM; SURVIVAL RATE;

EID: 84856658392     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1686-3     Document Type: Article

References (36)

1. LA Liotta K Tryggvason S Garbisa, et al. 1980 Metastatic potential correlates with enzymatic degradation of basement membrane collagen Nature. 284 6 67 10.1038/284067a0
2. SL Parsons SA Watson PD Brown, et al. 1997 Matrix metalloproteinases Br J Surg. 84 160 166 9052425 10.1002/bjs.1800840206 1:STN:280:DyaK2s3gsV2iug%3D%3D
3. S Curran GI Murray 2000 Matrix metalloproteinases: Molecular aspects of their roles in tumour invasion and metastasis Eur J Cancer. 36 1621 1630 10959048 10.1016/S0959-8049(00)00156-8 1:CAS:528:DC%2BD3cXlvFSrs7Y%3D
4. H Nagase JF Woessner Jr 1999 Matrix metalloproteinases J Biol Chem. 274 21491 21494 10419448 10.1074/jbc.274.31.21491 1:CAS:528:DyaK1MXltVynu7s%3D
5. AR Nelson B Fingleton ML Rothenberg, et al. 2000 Matrix metalloproteinases: Biologic activity and clinical implications J Clin Oncol. 18 1135 1149 10694567 1:CAS:528:DC%2BD3cXitVCgsbg%3D
6. HI Park J Ni FE Gerkema, et al. 2000 Identification and characterization of human endometase (matrix metalloproteinase-26) from endometrial tumor J Biol Chem. 275 20540 20544 10801841 10.1074/jbc.M002349200 1:CAS:528: DC%2BD3cXkvVyhsL4%3D
7. WG Stetler-Stevenson 2001 The role of matrix metalloproteinases in tumor invasion, metastasis and angiogenesis Surg Oncol Clin North Am. 10 383 392 1:STN:280:DC%2BD3M3ps1eitQ%3D%3D
8. M Hidalgo SG Eckhardt 2001 Development of matrix metalloproteinase inhibitors in cancer therapy J Natl Cancer Inst. 93 178 193 11158186 10.1093/jnci/93.3.178 1:CAS:528:DC%2BD3MXhtlKiurw%3D
9. S Curran GI Murray 1999 Matrix metalloproteinases in tumour invasion and metastasis J Pathol. 189 300 308 10547590 10.1002/(SICI)1096-9896(199911)189: 3<300::AID-PATH456>3.0.CO;2-C 1:CAS:528:DyaK1MXntlGgtbo%3D
10. WG Stetler-Stevenson 1990 Type IV collagenases in tumor invasion and metastasis Cancer Metastasis Rev Cancer Metastasis Rev. 9 289 303 1:STN:280:DyaK3M3ms1elsg%3D%3D
11. AF Chambers LM Matrisian 1997 Changing views of the role of matrix metalloproteinases in metastasis J Natl Cancer Inst. 89 1260 1270 9293916 10.1093/jnci/89.17.1260 1:CAS:528:DyaK2sXmt1Squ7g%3D
12. LA Liotta WG Stetler-Stevenson 1990 Metalloproteinases and cancer invasion Semin Cancer Biol. 1 99 106 2103492 1:STN:280:DyaK3MzlsF2lsw%3D%3D
13. S McDonnell M Navre RJ Coffey Jr, et al. 1991 Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas Mol Carcinog. 4 527 533 1793490 10.1002/mc.2940040617 1:CAS:528:DyaK38XhvFWrsbY%3D
14. C Pyke E Ralfkiaer K Tryggvason, et al. 1993 Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer Am J Pathol. 142 359 365 8434636 1:CAS:528:DyaK3sXkt1Glsrc%3D
15. M Yoshimoto F Itoh H Yamamoto, et al. 1993 Expression of MMP-7 (PUMP-1) mRNA in human colorectal cancers Int J Cancer 19 54 614 618 10.1002/ijc. 2910540415
16. ZS Zeng JG Guillem 1996 Colocalisation of matrix metalloproteinase-9 mRNA and protein in human colorectal cancer stromal cells Br J Cancer. 74 1161 1167 8883399 10.1038/bjc.1996.511 1:CAS:528:DyaK28Xnt1Shsrg%3D
17. ZS Zeng Y Huang AM Cohen, et al. 1996 Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9 J Clin Oncol. 14 3133 3140 8955659 1:STN:280:DyaK2s7htlyiuw%3D%3D
18. R Poulsom M Pignatelli WG Stetler-Stevenson, et al. 1992 Stromal expression of 72 kDa type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia Am J Pathol. 141 389 396 1323219 1:STN:280:DyaK38zlvFagug%3D%3D
19. R Roy J Yang MA Moses 2009 Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer J Clin Oncol. 27 5287 5297 19738110 10.1200/JCO.2009.23.5556 1:CAS:528:DC%2BD1MXhsFahsLnP
20. M Hilska PJ Roberts YU Collan, et al. 2007 Prognostic significance of matrix metalloproteinases-1, -2, -7 and -13 and tissue inhibitors of metalloproteinases-1, -2, -3 and -4 in colorectal cancer Int J Cancer. 121 714 723 17455256 10.1002/ijc.22747 1:CAS:528:DC%2BD2sXotleqtbo%3D
21. S Curran SR Dundas J Buxton MF Leeman R Ramsay GI Murray 2004 Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers Clin Cancer Res. 10 8229 8234 15623598 10.1158/1078-0432.CCR-04-0424 1:CAS:528:DC%2BD2cXhtFGjsrnK
22. MS Lyall SR Dundas S Curran GI Murray 2006 Profiling markers of prognosis in colorectal cancer Clin Cancer Res. 12 1184 1191 16489072 10.1158/1078-0432.CCR-05-1864 1:CAS:528:DC%2BD28XhsFaltL8%3D
23. R Bendardaf A Buhmeida M Hilska, et al. 2010 MMP-9 (gelatinase B) expression is associated with disease-free survival and disease-specific survival in colorectal cancer patients Cancer Invest. 28 38 43 20001295 10.3109/07357900802672761 1:CAS:528:DC%2BD1MXhsFCiu73N
24. J Kononen L Bubendorf A Kallionimeni, et al. 1998 Tissue microarrays for high-throughput molecular profiling of tumor specimens Nat Med. 4 844 847 9662379 10.1038/nm0798-844 1:CAS:528:DyaK1cXktlKntr8%3D
25. A Rhodes B Jasani DM Barnes, et al. 2000 Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems J Clin Pathol. 53 125 130 10767828 10.1136/jcp.53.2.125 1:STN:280:DC%2BD3c3jtVelsA%3D%3D
26. J Wang 2006 Current and future situation of colorectal carcinoma screening J Dig Surg. 5 303 305
27. A Jemal R Siegel E Ward, et al. 2009 Cancer statistics, 2009 CA Cancer J Clin. 59 225 249 19474385 10.3322/caac.20006
28. BM Wolpin JA Meyerhardt HJ Mamon, et al. 2007 Adjuvant treatment of colorectal cancer CA Cancer J Clin. 57 168 185 17507442 10.3322/canjclin.57.3. 168
29. MM Center A Jemal RA Smith, et al. 2009 Worldwide variations in colorectal cancer CA Cancer J Clin. 59 366 378 19897840 10.3322/caac.20038
30. PM Wilson MJ Labonte HJ Lenz 2010 Molecular markers in the treatment of metastatic colorectal cancer Cancer J. 16 262 272 20526105 10.1097/PPO. 0b013e3181e07738 1:CAS:528:DC%2BC3cXovV2rtLw%3D
31. P Ring K Johansson M Höyhtyä, et al. 1997 Expression of tissue inhibitor of metalloproteinases TIMP-2 in human colorectal cancer-a predictor of tumour stage Br J Cancer. 76 805 811 9310250 10.1038/bjc.1997.466 1:CAS:528:DyaK2sXmsVantbY%3D
32. ZR Peng WH Zhong J Liu, et al. 2010 Effects of the combination of hyperbaric oxygen and 5-fluorouracil on proliferation and metastasis of human nasopharyngeal carcinoma CNE-2Z cells Undersea Hyperb Med. 37 141 150 20568543 1:CAS:528:DC%2BC3cXot1aqt78%3D
33. U Coskun D Yamac O Gulbahar, et al. 2007 Locally advanced breast carcinoma treated with neoadjuvant chemotherapy: are the changes in serum levels of YKL-40, MMP-2 and MMP-9 correlated with tumor response? Neoplasma. 54 348 352 17845129 1:CAS:528:DC%2BD1cXhs1aqtA%3D%3D
34. W Wang HL McLeod J Cassidy 2003 Disulfiram-mediated inhibition of NF-kappaB activity enhances cytotoxicity of 5-fluorouracil in human colorectal cancer cell lines Int J Cancer. 104 504 511 12584750 10.1002/ijc.10972 1:CAS:528:DC%2BD3sXisVejt7c%3D
35. T Tamatani M Azuma Y Ashida, et al. 2004 Enhanced radiosensitization and chemosensitization in NF-kappaB-suppressed human oral cancer cells via the inhibition of gamma-irradiation- and 5-FU-induced production of IL-6 and IL-8 Int J Cancer. 108 912 921 14712497 10.1002/ijc.11640 1:CAS:528: DC%2BD2cXht1CitLc%3D
36. H Kyllönen AK Pasanen O Kuittinen, et al. 2009 Lack of prognostic value of MMP-9 expression and immunohistochemically defined germinal center phenotype in patients with diffuse large B-cell lymphoma treated with modern chemotherapy with or without CD20 antibody Leuk Lymphoma. 50 1301 1307 19811332 10.1080/10428190903003244